IN THE NEWS
Cardiac Science AED Software Update to be Available Ahead of Previous EstimatesUpdate available to US customers beginning February 2010
PRNewswire via COMTEX News Network
BOTHELL, Wash., -- Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, accelerated the availability date to February 2010 for the AED software update announced on November 13, 2009, well in advance of the previously estimated May 2010 date.
The software will enhance the AEDs' self-test capabilities and improve detection of a component-related issue in certain AEDs manufactured between August 2003 and August 2009. The Company had announced a voluntary field correction on these AEDs on November 13, 2009. In that announcement, the company estimated the software update would be available by May 2010.
The Company has since been able to substantially accelerate the delivery schedule and the software update will now be available to customers of certain models beginning the second half of February. The Company currently anticipates the software update to be available to all affected customers by the end of March 2010.
Customers will be notified by letter when the software update for their affected model is available. The software update will be made available for download at http://www.cardiacscience.com/AED175. At that site, customers who prefer printed documentation and a CD with the software update from the Company may request it.
Cardiac Science President and CEO Dave Marver said, "We have made every effort to accelerate the development of the software update and are pleased to make this field correction available to our customers earlier than expected."
As before, the Company strongly advises customers to follow the normal testing and maintenance procedures found in the Operator and Service Manual. A copy of these procedures is available at http://www.cardiacscience.com/AED175. At this site, customers may confirm if their AED is affected and register for automatic e-mail reminders to conduct scheduled maintenance.
About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the
Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT
For more information, contact (media) firstname.lastname@example.org | (investors) email@example.com | +91.80.2852.8088